Indications for the sclerosing agent polidocanol: response.
Geux
J J
JJ
D006801:Humans; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D015911:Sclerotherapy
D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols